Finance

Lists
Why is S0N0 down 4.92%?
Dive Deeper
S0N0:FRA
enGene Therapeutics Inc
€1.35
-4.92%
(-0.070) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for S0N0...
Open
€1.39
High
€1.39
Low
€1.35
Mkt. cap
105.89M
Avg. vol.
9.00
Volume
0.00
52-wk high
€7.36
52-wk low
€1.02
No. of employees
82
Open
€1.39
High
€1.39
Low
€1.35
Mkt. cap
105.89M
Avg. vol.
9.00
Volume
0.00
52-wk high
€7.36
52-wk low
€1.02
No. of employees
82
News stories
From web sources and news partners
About enGene Therapeutics Inc
CEO-
Employees82
Founded-
Headquarters-
SectorBiotechnology
Websiteengene.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
31.72M
22.26M
22.20M
20.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.76M
8.93M
9.77M
13.92M
Operating expense
39.48M
31.18M
31.97M
34.01M
Total operating expenses
39.48M
31.18M
31.97M
34.01M
Operating income
-39.48M
-31.18M
-31.97M
-34.01M
Other non operating income
448.00K
-
-
-
EBT including unusual items
-38.38M
-29.75M
-30.23M
-32.50M
EBT excluding unusual items
-38.38M
-29.26M
-30.23M
-32.50M
Income tax expense
-497.00K
-
-
-
Effective tax rate
1.29%
-
-
-
Other operating expenses
-
-
-
-
Net income
-37.88M
-29.75M
-30.23M
-32.50M
Net profit margin
-
-
-
-
Earnings per share
-0.73
-0.44
-0.43
-0.47
Interest and investment income
1.98M
2.74M
2.66M
2.40M
Interest expense
-750.00K
-732.00K
-745.00K
-843.00K
Net interest expenses
1.22M
2.01M
1.92M
1.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
-39.31M
-31.00M
-31.79M
-33.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps